These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10663666)

  • 21. [Effect of bloodletting on the proliferative activity of erythroid progenitor cells from the bone marrow of patients with polycythemia and polycythemia vera].
    Hansz J; Kozłowska-Skrzypczak M
    Pol Arch Med Wewn; 1991 Sep; 86(3):125-31. PubMed ID: 1808597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Megakaryocytopoiesis in polycythemia vera: characterization by megakaryocytic progenitors (CFU-Meg) in vitro and quantitation of marrow megakaryocytes.
    Kimura H; Ohkoshi T; Matsuda S; Uchida T; Kariyone S
    Acta Haematol; 1988; 79(1):1-6. PubMed ID: 3124455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural, antigenetic and transcriptional characteristics in peripheral blood CD34+ progenitor cells from polycythemia vera patients: evidence for delayed determination.
    Wickenhauser C; Pérez F; Siebolts U; Lorenzen J; Varus E; Frimpong S; Thiele J
    Int J Oncol; 2003 Aug; 23(2):437-43. PubMed ID: 12851693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro studies of human pluripotential hematopoietic progenitors in polycythemia vera. Direct evidence of stem cell involvement.
    Ash RC; Detrick RA; Zanjani ED
    J Clin Invest; 1982 May; 69(5):1112-8. PubMed ID: 7068849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic criteria of the myeloproliferative disorders (MPD): essential thrombocythaemia, polycythaemia vera and chronic megakaryocytic granulocytic metaplasia.
    Michiels JJ
    Neth J Med; 1997 Aug; 51(2):57-64. PubMed ID: 9286142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosing polycythemia vera: a paradigm shift.
    Tefferi A
    Mayo Clin Proc; 1999 Feb; 74(2):159-62. PubMed ID: 10069355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of murine JAK2V617F-positive myeloproliferative disease.
    Bumm TG; Elsea C; Corbin AS; Loriaux M; Sherbenou D; Wood L; Deininger J; Silver RT; Druker BJ; Deininger MW
    Cancer Res; 2006 Dec; 66(23):11156-65. PubMed ID: 17145859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Standardization and comparison of endogenous erythroid colony assays performed with bone marrow or blood progenitors for the diagnosis of polycythemia vera.
    Dobo I; Donnard M; Girodon F; Mossuz P; Boiret N; Boukhari R; Allégraud A; Bascans E; Campos L; Pineau D; Turlure P; Praloran V; Hermouet S
    Hematol J; 2004; 5(2):161-7. PubMed ID: 15048067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous erythroid colony assay in patients with polycythemia vera and its clinical significance.
    Bai J; Shao ZH; Liu H; Shi J; He GS; Cao YR; Cui ZZ; Wu YH; Sun J; Tian Z; Jia HR; Qian LS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 May; 117(5):668-72. PubMed ID: 15161531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased erythropoiesis in polycythemia vera is associated with increased erythroid progenitor proliferation and increased phosphorylation of Akt/PKB.
    Dai C; Chung IJ; Krantz SB
    Exp Hematol; 2005 Feb; 33(2):152-8. PubMed ID: 15676208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic mutations of JAK2 exon 12 as a molecular basis of erythrocytosis.
    Cazzola M
    Haematologica; 2007 Dec; 92(12):1585-9. PubMed ID: 18055979
    [No Abstract]   [Full Text] [Related]  

  • 32. Erythroid progenitors in polycythemia vera.
    Varet B; Casadevall N; Lacombe C
    Blood Cells; 1981; 7(1):125-32. PubMed ID: 7187745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia.
    Bellucci S; Michiels JJ
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):381-98. PubMed ID: 16810614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polycythemia Vera.
    Spivak JL
    Curr Treat Options Oncol; 2018 Mar; 19(2):12. PubMed ID: 29516275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycythemia vera: scientific advances and current practice.
    Tefferi A; Spivak JL
    Semin Hematol; 2005 Oct; 42(4):206-20. PubMed ID: 16210034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow morphologic features in polycythemia vera with JAK2 exon 12 mutations.
    Lakey MA; Pardanani A; Hoyer JD; Nguyen PL; Lasho TL; Tefferi A; Hanson CA
    Am J Clin Pathol; 2010 Jun; 133(6):942-8. PubMed ID: 20472853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of histologic examination of the bone marrow in the differential diagnosis of polycythemia].
    Lacheta L; Spychałowicz W; Machalski M; Białas B; Siudyka A
    Wiad Lek; 1988 Jul; 41(13):894-8. PubMed ID: 3239032
    [No Abstract]   [Full Text] [Related]  

  • 38. [Polycythemia: primary or secondary? The differential diagnostic value of stem cell cultures].
    Küng C; Huxol H; Müller R; Speck B; Nissen C
    Schweiz Med Wochenschr; 1993 Jan; 123(3):53-6. PubMed ID: 8426948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective study of the value of bone marrow erythroid progenitor cultures in polycythemia.
    Lemoine F; Najman A; Baillou C; Stachowiak J; Boffa G; Aegerter P; Douay L; Laporte JP; Gorin NC; Duhamel G
    Blood; 1986 Nov; 68(5):996-1002. PubMed ID: 3768535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis.
    Tefferi A; Yoon SY; Li CY
    Blood; 2000 Jul; 96(2):771-2. PubMed ID: 10887148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.